Dr. Rose Gelineau-Morel, MD
Claim this profileClinical Trials Rose Gelineau-Morel, MD is currently running
More about Rose Gelineau-Morel, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Rose Gelineau-Morel, MD has experience with
- Trihexyphenidyl
Breakdown of trials Rose Gelineau-Morel, MD has run
Cerebral Palsy
Focal Dystonias
Drug Interaction
Genetic Predisposition
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rose Gelineau-Morel, MD specialize in?
Rose Gelineau-Morel, MD focuses on Cerebral Palsy and Focal Dystonias. In particular, much of their work with Cerebral Palsy has involved treating patients, or patients who are undergoing treatment.
Is Rose Gelineau-Morel, MD currently recruiting for clinical trials?
Yes, Rose Gelineau-Morel, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Rose Gelineau-Morel, MD has studied deeply?
Yes, Rose Gelineau-Morel, MD has studied treatments such as Trihexyphenidyl.
What is the best way to schedule an appointment with Rose Gelineau-Morel, MD?
Apply for one of the trials that Rose Gelineau-Morel, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.